These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 9086445)

  • 1. Nature of the T lymphocytes in lymphocyte predominance Hodgkin's disease.
    Dargent JL; Schandene L; Kornreich A; Lespagnard L; Cochaux P; Jagodzinski R; Capel P; Velu T; Neve P
    Leuk Lymphoma; 1997 Feb; 24(5-6):545-51. PubMed ID: 9086445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
    Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
    Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of blood lymphocyte CTLA-4 (CD152) induction in Hodgkin's disease with proliferative activity, interleukin 2 and interferon-gamma production.
    Kosmaczewska A; Frydecka I; Boćko D; Ciszak L; Teodorowska R
    Br J Haematol; 2002 Jul; 118(1):202-9. PubMed ID: 12100149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional evaluation of T-lymphocytes from peripheral blood and spleens in Hodgkin's disease.
    Mukhopadhyaya R; Advani SH; Gangal SG
    Br J Cancer; 1987 Dec; 56(6):800-2. PubMed ID: 2829954
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytokine gene expression profile distinguishes CD4+/CD57+ T cells of the nodular lymphocyte predominance type of Hodgkin's lymphoma from their tonsillar counterparts.
    Atayar C; Poppema S; Visser L; van den Berg A
    J Pathol; 2006 Feb; 208(3):423-30. PubMed ID: 16353293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment in proliferation, lymphokine production and frequency distribution of mitogen-responsive and interleukin-2-producing cells in Hodgkin's disease.
    Damle RN; Advani SH; Gangal SG
    Cancer Immunol Immunother; 1991; 34(3):205-10. PubMed ID: 1756538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoreactivities of Reed-Sternberg cells and their variants in the sequential biopsy of Hodgkin's disease.
    Ohsawa M; Aozasa K; Ikeda H
    Mod Pathol; 1993 Jul; 6(4):457-62. PubMed ID: 8415592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic profile in patients with Hodgkin's disease in complete remission.
    Liberati AM; Ballatori E; Fizzotti M; Schippa M; Proietti MG; Di Marzio R; Pecci A; Biscetti L; Sbarretti R; Cini L
    Cancer; 1987 Jun; 59(11):1906-13. PubMed ID: 3105863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the lymphocytes surrounding Reed-Sternberg cells in nodular lymphocyte predominance and in other types of Hodgkin's disease.
    Poppema S
    Am J Pathol; 1989 Aug; 135(2):351-7. PubMed ID: 2675617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical analysis of the distribution of lymphocyte subpopulations in Hodgkin's disease.
    Borowitz MJ; Croker BP; Metzgar RS
    Cancer Treat Rep; 1982 Apr; 66(4):667-74. PubMed ID: 6210433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The distinction of Hodgkin's disease from B cell lymphoma.
    Warnke RA
    Semin Diagn Pathol; 1992 Nov; 9(4):284-90. PubMed ID: 1480850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro characterization of T and B lymphocytes in chronic lymphatic leukemia and Hodgkin's disease.
    Tursi A; Ferrannini A; Losito G
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:306. PubMed ID: 4604590
    [No Abstract]   [Full Text] [Related]  

  • 13. SPLEEN/PATHOL.
    Bukowski RM; Noguchi S; Hewlett JS; Deodhar S
    Am J Clin Pathol; 1976 Jan; 65(1):30-9. PubMed ID: 1082240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two subsets of human CD4+ T helper cells differing in kinetics and capacities to produce interleukin 2 and interferon-gamma can be defined by the Leu-18 and UCHL1 monoclonal antibodies.
    Dohlsten M; Hedlund G; Sjögren HO; Carlsson R
    Eur J Immunol; 1988 Aug; 18(8):1173-8. PubMed ID: 2970968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired proliferative response and low interleukin-2 production in patients with lymphoma.
    Musatti CC; Yasaka K; Santos LM
    Braz J Med Biol Res; 1987; 20(3-4):351-62. PubMed ID: 3502537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The patterns of IL2, IFN-gamma, IL4 and IL5 gene expression in Hodgkin's disease and reactive lymph nodes are similar.
    Serrano D; Ghiotto F; Roncella S; Airoldi I; Cutrona G; Truini M; Burgio VL; Baroni CD; Ferrarini M; Pistoia V
    Haematologica; 1997; 82(5):542-9. PubMed ID: 9407718
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hodgkin's disease--immunological aspects].
    Plat M; Frank KH; Fleischer J; Plat U; Koslowski R
    Allerg Immunol (Leipz); 1988; 34(3):139-58. PubMed ID: 3057835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin lymphoma.
    Marshall NA; Christie LE; Munro LR; Culligan DJ; Johnston PW; Barker RN; Vickers MA
    Blood; 2004 Mar; 103(5):1755-62. PubMed ID: 14604957
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.
    von Wasielewski R; Werner M; Fischer R; Hansmann ML; Hübner K; Hasenclever D; Franklin J; Sextro M; Diehl V; Georgii A
    Am J Pathol; 1997 Mar; 150(3):793-803. PubMed ID: 9060817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.
    Austin LM; Ozawa M; Kikuchi T; Walters IB; Krueger JG
    J Invest Dermatol; 1999 Nov; 113(5):752-9. PubMed ID: 10571730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.